338 related articles for article (PubMed ID: 23678709)
1. [Expressions of SIgA and alpha 1-AR in benign prostatic hyperplasia combined with chronic prostatitis and their implications].
Gao WJ; Wang YM; Wang CH; Yang XK; Wan L; Li WP
Zhonghua Nan Ke Xue; 2013 Apr; 19(4):315-20. PubMed ID: 23678709
[TBL] [Abstract][Full Text] [Related]
2. [Clinical features of benign prostatic hyperplasia complicated by chronic prostatitis].
Chang DG; Li GS; Zhang PH; Wu TL; Mei XF; Cao J; Gao P
Zhonghua Nan Ke Xue; 2010 Sep; 16(9):830-3. PubMed ID: 21171270
[TBL] [Abstract][Full Text] [Related]
3. Seminal plasma cytokines and chemokines in prostate inflammation: interleukin 8 as a predictive biomarker in chronic prostatitis/chronic pelvic pain syndrome and benign prostatic hyperplasia.
Penna G; Mondaini N; Amuchastegui S; Degli Innocenti S; Carini M; Giubilei G; Fibbi B; Colli E; Maggi M; Adorini L
Eur Urol; 2007 Feb; 51(2):524-33; discussion 533. PubMed ID: 16905241
[TBL] [Abstract][Full Text] [Related]
4. [Correlation of histological prostatitis with PSA, prostate volume, PSAD, IPSS, Qmax and PVR in BPH patients].
Zhang HT; Xu Y; Chang JW; Zhang ZH; Liu RL; Ma BJ
Zhonghua Nan Ke Xue; 2012 Mar; 18(3):208-11. PubMed ID: 22474983
[TBL] [Abstract][Full Text] [Related]
5. [Correlation of IPSS with IL-8 and COX-2 levels in patients with benign prostatic hyperplasia and prostatitis].
Chen DA; Yang XZ; Zhang PH; Li GS; Chang DG
Zhonghua Nan Ke Xue; 2013 Jun; 19(6):527-30. PubMed ID: 23862231
[TBL] [Abstract][Full Text] [Related]
6. [Expression of estrogen receptor beta in benign prostatic hyperplasia complicated by chronic prostatitis].
Yang GQ; Li SW; Zheng H; Zhang WB; Hu WL; Zheng XM
Zhonghua Nan Ke Xue; 2009 Apr; 15(4):314-7. PubMed ID: 19472903
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of interleukin-8 in expressed prostatic secretion as a reliable biomarker of inflammation in benign prostatic hyperplasia.
Liu L; Li Q; Han P; Li X; Zeng H; Zhu Y; Wei Q
Urology; 2009 Aug; 74(2):340-4. PubMed ID: 19464042
[TBL] [Abstract][Full Text] [Related]
8. [Expressions of the androgen receptor in normal prostate, benign prostatic hyperplasia and prostate cancer].
Zeng R; Liu ZY; Sun YH; Xu CL; Gao X; Jiao L
Zhonghua Nan Ke Xue; 2010 Nov; 16(11):967-72. PubMed ID: 21218636
[TBL] [Abstract][Full Text] [Related]
9. [Benign prostate hyperplasia with chronic prostatitis: an update].
Ma Y; Zhang WL
Zhonghua Nan Ke Xue; 2010 Jul; 16(7):646-50. PubMed ID: 20873602
[TBL] [Abstract][Full Text] [Related]
10. [A clinical analysis of benign prostatic hyperplasia with chronic prostatitis].
Wu XJ; Yang LY; Zhang XZ
Zhonghua Nan Ke Xue; 2008 Jun; 14(6):527-9. PubMed ID: 18649752
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of histological prostatitis in men with benign prostatic hyperplasia or adenocarcinoma of the prostate presenting without urinary retention.
Edlin RS; Heyns CF; Van Vuuren SP; Zarrabi AD
S Afr J Surg; 2012 Nov; 50(4):127-30. PubMed ID: 23217554
[TBL] [Abstract][Full Text] [Related]
12. Significance of histological prostatitis in patients with urinary retention and underlying benign prostatic hyperplasia or adenocarcinoma of the prostate.
van Vuuren SP; Heyns CF; Zarrabi AD
BJU Int; 2012 Apr; 109(8):1194-7. PubMed ID: 21851551
[TBL] [Abstract][Full Text] [Related]
13. [LUTS in BPH patients with histological prostatitis before and after transurethral resection of the prostate].
Huang XH; Qin B; Liang YW; Wu QG; Li CZ; Wei GS; Ji HC; Liang YB; Chen HQ; Guan T
Zhonghua Nan Ke Xue; 2013 Jan; 19(1):35-9. PubMed ID: 23469659
[TBL] [Abstract][Full Text] [Related]
14. Fat boosts, while androgen receptor activation counteracts, BPH-associated prostate inflammation.
Vignozzi L; Gacci M; Cellai I; Santi R; Corona G; Morelli A; Rastrelli G; Comeglio P; Sebastanelli A; Maneschi E; Nesi G; De Nunzio C; Tubaro A; Mannucci E; Carini M; Maggi M
Prostate; 2013 Jun; 73(8):789-800. PubMed ID: 23620238
[TBL] [Abstract][Full Text] [Related]
15. [Expressions of integrinalpha2beta1 and CD133 in benign prostatic hyperplasia complicated by prostatitis and their significance].
Ding Q; Miao WL; Liu S; Chang JW; Yang YM
Zhonghua Nan Ke Xue; 2011 Oct; 17(10):909-12. PubMed ID: 22049795
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical expression of interleukin-2 receptor and interleukin-6 in patients with prostate cancer and benign prostatic hyperplasia: association with asymptomatic inflammatory prostatitis NIH category IV.
Engelhardt PF; Seklehner S; Brustmann H; Lusuardi L; Riedl CR
Scand J Urol; 2015 Apr; 49(2):120-6. PubMed ID: 25363611
[TBL] [Abstract][Full Text] [Related]
17. Oxidative stress--cause or consequence of male genital tract disorders?
Kullisaar T; Türk S; Punab M; Mändar R
Prostate; 2012 Jun; 72(9):977-83. PubMed ID: 22025397
[TBL] [Abstract][Full Text] [Related]
18. [Vinculin and the androgen receptor in prostate cancer: expressions and correlations].
Zhu LY; Zhong KB; Lu SX; He LY
Zhonghua Nan Ke Xue; 2010 Sep; 16(9):794-8. PubMed ID: 21171262
[TBL] [Abstract][Full Text] [Related]
19. The effect of prostate tissue inflammation in benign prostatic hyperplasia on enhancer of zeste homolog 2 ribonucleic acid expression.
Al-Maghrebi M; Kehinde EO; Al-Mulla F; Anim JT
Ann Saudi Med; 2012; 32(3):262-8. PubMed ID: 22588437
[TBL] [Abstract][Full Text] [Related]
20. [The relationship between anaphylatoxin C3a and benign prostatic hyperplasia with inflammation].
Xie L; Cheng SL; Li YZ; Liu LR; Han P; Chen N; Wei Q; Zhou Q
Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Sep; 42(5):642-5. PubMed ID: 22007489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]